The above-mentioned paper requires a few comments: 1) The statement 'blood loss and borderline anemia resulted in increases of erythropoietin concentrations which exceeded the physiological range by less than factor 7 ...' is misleading. Physiological concentrations of erythropoietin (EPO) range from 11 to 31 U/ml (5-95 percentile) [1] . The highest EPO levels presented in the study (day 21, prior to 4th donation) were 43 ± 14 mU/ml in men and 43 ± 23 mU/ml in women. These concentrations were only moderately above the physiological range and by no means close to factor 7. Such a moderate increase of erythropoietin serum concentration prior to each donation had been reported previously [2] . 2) The EPO concentration prior to each autologous donation does not properly reflect the response of serum EPO to phlebotomy. EPO concentrations after autologous donation show a biphasic pattern: A peak concentration on the first day after phlebotomy is followed by a plateau phase at a lower but still elevated level [3, 4] . 3) Total red blood cell volume should be calculated correcting large-vessel hematocrit to total-body hematocrit [5] . 4) On the basis of the formula of Nadler et al. [6] , the total red blood cell volume and the volume of red blood cells regenerated during the donation period may be underestimated. In chronically anemic patients blood volume may be greater than in patients with hemoglobin concentrations in the normal range [7] . This should at least be discussed. 5) Calculation of the net gain of erythrocytes should take into account that erythrocytes are lost during the production of buffy coat-poor packed red blood cells and during storage. These losses may well amount to more than 10% of the red blood cells initially collected.
A. Lorentz, Mannheim

Author's Reply
We appreciate the comments by A. Lorentz encouraging us to discuss our findings in greater detail.
Concerning comments 1 and 2:
The aim of our study was not to describe the physiological erythropoietin (EPO) response to blood loss, but we rather sought for an indicator of erythropoiesis. Therefore, the EPO levels obtained during the plateau phase before the days of donation -even after a decline [1] -seemed more suitable than a short-lived increase of EPO levels to reflect blood lossinduced effects. In our study EPO levels reached a maximum of 85 U/l. We agree with A. Lorentz that the statement '... less than factor 7' was vague in that individual increases less than 7-fold were observed; however, the physiological range is not clearly defined. Normal EPO ranges other than 11-31 U/l as published by Lorentz et al. [1] are 4-26 U/l [2] and, as an approximation, 10-20 U/l [3] and coincide with our baseline EPO concentrations before the first donation (men 18 ± 6.2 U/l, women 13 ± 5.2 U/l). (The paper of Eckhardt et al. [4] cited by A. Lorentz does not state a physiological EPO range.) Concerning comments 3 and 4:
We are aware that our calculations of total red blood cell (RBC) volumes are indirect measurements utilizing body weight, height and hematocrit. Since body weight and height were assumed as being constant over 5 weeks, hematocrit was the only parameter to influence calculations of RBC volume. Our findings are mainly based on changes of hematocrit and hemoglobin. Therefore, total body RBC volumes as an absolute measure were of minor importance. Furthermore, the equations developed by Nadler et al. [5] which were utilized for our calculations already include a correction factor of 0.91 for the venous/body hematocrit ratio. Thus this factor was already included in our calculations. Finally, Najean and De-schrywer [6] stated that the small variation of '... results around the mean value makes the potential error very low ... in polycythaemic and normal subjects'. In their publication on transfused patients with homozygous beta-thalassemia Gabutti et al. [7] stated that, with a hemoglobin level '... above 12 g/dl, the blood volume is nearly normal'. The donors included in our study had no thalassemia, were neither chronically anemic, nor transfused, most of them had hemoglobin concentrations above 12 g/dl and were therefore regarded as normal subjects in whom only minor differences between calculated and true hemoglobin concentrations were to be expected. Concerning comment 5: A. Lorentz correctly points out that approximately 50 ml of buffy coat (10%) is lost during separation of 500 ml whole blood in an RBC concentrate and plasma. The partial loss of erythrocyte viability during storage was also disregarded in our study. However, both factors pertain to the availability of donated RBCs at surgery, and were not an objective of our study. Instead, the purpose was to describe the balance between blood donation and RBC regeneration.
